Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

Lower LDL-c levels predict higher COVID-19 mortality.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Anabolic steroid users may face higher risk of severe COVID-19.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

A boy with a rare skin condition improved quickly after starting zinc supplements.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

COVID-19 vaccines do not increase the risk of alopecia areata.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

A team of different healthcare experts is good for treating long-term COVID-19 issues.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

The study concludes that the new clinical scoring system is a quick, low-cost, and accurate method for diagnosing COVID-19.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

A patient experienced severe hair loss after getting an mRNA COVID-19 vaccine.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

COVID-19 can cause different types of hair loss, and proper diagnosis by a specialist may be needed.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

Testosterone's effects on COVID-19 are unclear and need more research.

Men on 5-alpha-reductase inhibitors might have worse COVID-19 outcomes.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.